Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The efficacy of subcutaneous immunoglobulin administration in chronic inflammatory demyelinating polyneuropathy responders to intravenous immunoglobulin.

× No keyword cloud information.

11 in total

1. An update on the management of chronic inflammatory demyelinating polyneuropathy.

Authors: Kenneth C Gorson
Journal: Ther Adv Neurol Disord Date: 2012-11 Impact factor: 6.570

2. Improvement of quality of life in patients with chronic inflammatory demyelinating polyneuropathy shifting from 16 to 20% subcutaneous immunoglobulins.

Authors: Dario Cocito; Ilaria Paolasso; Erdita Peci; Emanuela Spagone; Leonardo Lopiano
Journal: Neurol Sci Date: 2013-04-11 Impact factor: 3.307

3. Switch from intravenous to subcutaneous immunoglobulin in CIDP and MMN: improved tolerability and patient satisfaction.

Authors: Robert D M Hadden; Fabrizio Marreno
Journal: Ther Adv Neurol Disord Date: 2015-01 Impact factor: 6.570

4. Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study.

Authors: Dario Cocito; Aristide Merola; Erdita Peci; Anna Mazzeo; Raffaella Fazio; Ada Francia; Paola Valentino; Rocco Liguori; Massimiliano Filosto; Gabriele Siciliano; Angelo Maurizio Clerici; Stefania Lelli; Girolama Alessandra Marfia; Giovanni Antonini; Ilaria Cecconi; Eduardo Nobile-Orazio; Leonardo Lopiano
Journal: J Neurol Date: 2014-08-23 Impact factor: 4.849

5. Subcutaneous immunoglobulin in treating inflammatory neuromuscular disorders.

Authors: Min-Suk Yoon; Ralf Gold; Antonios Kerasnoudis
Journal: Ther Adv Neurol Disord Date: 2015-07 Impact factor: 6.570

6. Subcutaneous vs intravenous administration of immunoglobulin in chronic inflammatory demyelinating polyneuropathy: an Italian cost-minimization analysis.

Authors: Carlo Lazzaro; Leonardo Lopiano; Dario Cocito
Journal: Neurol Sci Date: 2014-01-28 Impact factor: 3.307

Review 7. Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside.

Authors: Amanda C Peltier; Peter D Donofrio
Journal: Semin Neurol Date: 2012-11-01 Impact factor: 3.420

8. Switch from intravenous to subcutaneous immunoglobulin IgPro20 in CIDP patients: a prospective observational study under real-world conditions.

Authors: Stefan Gingele; Moritz Koch; Anna Christina Saparilla; Gudrun M Körner; Jarle von Hörsten; Marina Gingele; Tabea Seeliger; Franz Felix Konen; Martin W Hümmert; Alexandra Neyazi; Martin Stangel; Thomas Skripuletz
Journal: Ther Adv Neurol Disord Date: 2021-04-16 Impact factor: 6.570

Review 9. Optimizing IgG therapy in chronic autoimmune neuropathies: a hypothesis driven approach.

Authors: Melvin Berger; Jeffrey A Allen
Journal: Muscle Nerve Date: 2015-01-29 Impact factor: 3.217

Review 10. Treatment of chronic inflammatory demyelinating polyneuropathy: from molecular bases to practical considerations.

Authors: Paolo Ripellino; Thomas Fleetwood; Roberto Cantello; Cristoforo Comi
Journal: Autoimmune Dis Date: 2014-01-14